Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study

Published:1983-08 Issue:8 Volume:19 Page:1097-1104
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Bramwell Vivien H.C.,Mouridsen H.T.,Mulder J.H.,Somers R.,Van Oosterom A.T.,Santoro A.,Thomas D.,Sylvester R.,Markham D.

Publisher

Elsevier BV

Subject

Oncology

Reference18 articles.

1. Chemotherapy of advanced soft tissue sarcoma in adults;Pinedo;Cancer Treat Rev,1977

2. Adriamycin (NSC-123127) used alone and in combination for soft tissue and bone sarcomas;Gottlieb;Cancer Chemother Rep,1975

3. Tabular analysis of the clinical chemotherapy of solid tumours;Wasserman;Cancer Chemother Rep,1975

4. Bone and soft tissue sarcomas;Bramwell,1979

5. Bone and soft tissue sarcomas;Bramwell,1980

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of first line chemotherapy regimens for advanced soft tissue sarcoma: a network meta-analysis;Journal of Chemotherapy;2021-04-19

2. Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation;BMC Cancer;2019-01-11

3. A meta-analysis of randomized controlled trials that compare standard doxorubicin with other first-line chemotherapies for advanced/metastatic soft tissue sarcomas;PLOS ONE;2019-01-10

4. Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas;Investigational New Drugs;2009-07-07

5. Carminomycin;xPharm: The Comprehensive Pharmacology Reference;2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3